Press releases
Regulatory press release 2025-11-05
Interim Report Third Quarter 2025
Regulatory press release 2025-10-10
Xspray Pharma’s Nomination Committee for the Annual General Meeting 2026
Regulatory press release 2025-10-08
Xspray Pharma provides update on the FDA process for Dasynoc – observations at contract manufacturer delay approval
Regulatory press release 2025-09-30
New number of shares and votes in Xspray Pharma after new share issue
Regulatory press release 2025-09-11
Xspray’s rights issue oversubscribed – over-allotment issue increased and fully utilized
-
Latest report
Interim Report Q3 2025 -
Subscribe
Get our latest press releases and reports